Loss of blood derivatives: Medical-surgical recommendations to reduce their use

Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso

The use of blood derivatives has been decreasing in medical practice due to the increase in diseases transmitted by transfusions and the clear knowledge of physicians when considering transfusion as a true transplant with all its complications. Surgeons are faced with the refusal of some patients to receive blood derivatives for personal or religious convictions, as in the case of Jehovah's Witnesses. There are many measures to reduce the use and loss of blood in surgery, ranging from a good surgical technique, through the use of substances that promote the volume of red blood cells, such as erythropoietin and iron, antifibrinolytic substances such as analogues of lysine, intraoperative measures to reduce blood loss, such as cell salvage and anesthetic techniques for the same purpose. In this article a Jehovah's Witness patient is presented, handled with some of these measures and a revision is made on the current recommendations in advanced transfusion practices.

1. Blood conservation and Transfusión alternatives 28th Congress of the International Society of Hematology, 2000 aug 26; Toronto, Canadá. P 5-48

2. Linder van der P. Perioperative blood conservation strategies: an update for clinicians. Can J of Anaesth 2003;.50 (6)

3. Code of practice for the surgical management oj jehovah's witnesses. London: Council of the Royal College of Surgeons of England, 2000. p 1-19; 35-43

4. The New York Center for Bloodless Medicine and sugery, guide. 2003, Br. J. Surg 1998; 75 (4): 44-48.

5. Glenn P. ¿Cómo puede salvarle la vida la sangre? 1990 watch Tower Bible and tract Society Pensilvania. Atalaya 1990; 23-7

6. Man M, Votto J, Kambe J. Managaement of the severely anemic patient who refuses transfusion: lessons learned during the care of a Jehovah's witness. Ann Intern Med 1992; 117: 1042-48.

7. Sagrada Biblia, XXXIX Congreso Eucarístico Internacional de Bogota, 1968.

8. Dixon L. Los testigos de Jehová el desafio quirúrgico JAMA 1981, nov; 246: 2471-72.

9. Dixon L. Transfusiones de sangre: ¿De quien es la decisión? ¿La conciencia de quien debe respetarse? J Med 1988; 88: 463-4.

10. Guzman MF, Morales de MC, Franco E. De la Responsabilidad Civil Médica. Bogotá: Ediciones Rosarista, 1995.

11. Cortes A. Alternativas farmacológicas a las transfusiones de sangre y componentes. Col Médica 1994;25:73-82.

12. Niels Q. Stten B. Birgit W. Carnsten P. Recombinant Human Erythropoietin and Hemoglobin Concentration at Operatio and during the postoperative period: Reduced need for blood transfusions in patients undergoing colorectal surgery- Prospective Double - blind placebo - controlled study. World J Sury 1999; 23: 30-5.

13. Rutherford C, Schneider T, Hilton D, David K. Efficacy of different regimens for recombinant human Erythropoietin in a simulated perisurgical setting: The importance of Iron availability in optimizing response. American J Med 1994; 96

14. Alexander K. Gombotz H. Gootfried F. Subcutaneous Recombinant Human Erythropoietin and autologous blood donation before coronary artery Bypass surgery. Anesthesia Analg 1993; 76: 102-6.

15. Adamson J. Spivak J. Physiologic basis for the pharmacologic use of reombinant human erythropoietin in surgery and cancer treatment. Surgery; Jan1994.

16. Guidelines Consensus Conference: Blood Management Surgical Practice Am J Surg; 1995: 170 (6A).

17. Ramos H, Satoru T, Yoog000 K. Evangelos F Howard D. Liver transplantation withouth the use of blood products. Arch Surg 1994; 129:528-533.

18. Cardemil G, Rodríguez M, Reyes D. Resultados del programa de atención medico-quirúrgica sin uso de sangre no hemoderivados del Hospital Clínico de la Universidad de Chile. Rev Chilena Cirugía 2004; 56 (3): 232-36.

19. Maclntyre A. Blood transfusion and hemostatic management in the perioperative period. Can J Anaesth 1992; 39 (5): Pt 2 R 101-14.

20. Fugh-Bermann A. Herb Drug interactions. Lancet 2002; 355 (9198): 134-38.

21. Faris P. Spende K, Larholt M.O. The predicitive power of baseline hemoglobinfor transfusion risk in surgeey patients. Orthopedics 1999:22 (1) Suppl S 135-40

22. Torzilli G, Makuuchi K. Inoue E. No mortality liver resection for hepatocelular carcinoma in cirrhotic and noncirrhotic patients; in there a way? A prospective analysis of our approach. Arch Surg 1999; 134 (9): 984-9.

23. Sabiston D,C. Principies of operative surgery: antisepsis, technique sutures and drains; Textbook of surgery ; the Biological Basis of Modem Surgical Practice, 15 th ed. Philadelphia. Saunders , 1997. pp. 253-63.

24. Amours D. Joshipura M, Introduction : Damage control at the start of 21st century. Sugrue M. Injury 2004; 35: suppl 639-41.

25. B,Cherqui R. Safety of selective vascular clamping for major hepatectomies. Malasagne. 1998; 187 (5): 482-86.

26. Schneeberger A, Schulz R. Blood loss in total hip arthroplasty. Lateral position combined with preservation of the capsule versus supine position combined with capsulectomy: Arch Orthop, Trauma Surg 1998; 117 (1-2): 47-9.

27. Postsplenectomy blood salvage in anemic patient; De Rai P.; Rebulla H.; JAMA, 258, N. 10 (1987),1332.

28. Evaluation of autologous she blood for autotransfusion alter orthopaedic surgery; Healy W.; Pfeifer S.; Kurtz U.; Clin. Orthop., N. 299 (1994), 53-59.

29. Conservation of blood during cardiovascular surgery, Cooley D.A; American Journal of Surgery , 170 , N. 6A, Suppl. (1995), 53S-59S.

30. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion ;Lentschesner C.; Cottin H., Anesth. Analg. 89, N. 3, (1999), 590-597.

31. Central venous pressure and its effect on blood loss during liver resection ; Jones R.; Moulton M.; Br. J. Surg. 85 N. 8 (1998), 1058-1060.

32. Pharmacologic drugs for controlled hypotension; Testa L.D.; Tobias F.; j. Clin. Anesth.,7, N. 4 (1995),326-337.

33. Scott N. B. Regional anaesthesia and surgical morbidity. Br, J, Surg 1099; 75 (4): 44-p.

34. Grass J. Surgical outcome: regional anesthesia and analgesia versus general anaesthesia. Anesthesiol 1993; 20 (4): 117- 125.

35. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction; J. Am. Coll. Surg 187, N. 6 (1998);620-625

36. Deliberate hypotensive anesthesia with labetalolin reconstructive surgery for scoliosis, Acta Anaesthesiol Sin, 34 N. 4; (1996); 203-207.

37. The role of desmopressin in reducing blood loss during lumbar fusions; Johnson R.; Murphy U.; Surg. Gynecol. Obstet.; 171, n. 3 (1990), 106-110.

38. Prevention of bleeding after cardiopulmonary bypass with high - dose tranexamic acid; Karski Y.; Teasdale R., J. Thorac. Cardiovasc. Surg. ,110, N.3, (1995), 835-42.

39. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass surgery : a double blind randomized palcebo controlled trial; Brown G.; Thwaites R.; Anesth. Analg. 85; n.5 (1997), 963-70.

40. Increased safety in the administration of aprotinin , need for a test dose; Llau V.; García- Pérez M., Nesth. Analg. 90, N. 3 (2000) , 770-71.

41. Kesten S.A. Hoyas de C. Chaparrto I. Aprtinin reduced blood loss in lung transplant recipiente Ann Thorac, Surg 1995; 59 (4): 877-879.

42. Lentschesner C, Cottin H. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion Anesth Analg 1999; 89 (3): 590-97.

43. aprotinin and transfusion requirements in orthoptic liver transplantation : a multicentric randomised double blind trial ; Porte Y., Moleenar T., Begliomini U ; Lancet, 335, N. 9212; (2000), 1303-1309.

44. Jaramillo M. Medicina Transfusional, Principios y practica medico quirúrgica. Bogotá: Proyecto Aventis, 2003.

45. Szalay D, Wong T, Lindsay T. Impact of red cell salvage on transfusión requirements during elective abdominal aortic aneurysm repair Ann. Vasc Surg 1999; 13 (6): 576-81.

46. Goodnough L. Monk G. Sicard H, J. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm reapir: an análisis of costs and benefits . J. Vasc. Surg 1996; 24 (2): 213-18.

47. Assesment of the availability of intraoperative autotransfusion in urological operations. J Urol 1997; 157 (5): 1777-80.

48. Heiss M, Anwar T. Delanoff C, Algayer H. Perisurgical erythropoietin application in anemic patients with colorectal cancer : A double - blind randomized study. Surgery 1996; my.